AMZN
Amazon.com, Inc.
AMZN has the edge over OI overall, supported by stronger fundamentals and stronger valuation.
OI
O-I Glass, Inc.
OI trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
OI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Under pressure | |
| Weak |
OI's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
OI PE Valuation
OI has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over OI on the outlook, with more favorable earnings and revenue expectations.
OI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Stable | |
| Weakening | |
| Limited | |
| Low |
Analysts expect OI's earnings and profitability to decline, with its revenue holding steady. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over OI on earnings quality, reporting a profit while its opponent remains loss making.
OI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.51 | — |
| Q3 2026 | -$7.79 | -$6.87 |
| Q2 2026 | -$7.52 | -$5.89 |
| Q1 2026 | -$1.22 | +$0.02 |
| Q4 2025 | -$0.84 | -$0.15 |
| Q3 2025 | -$0.92 | +$1.76 |
| Q2 2025 | -$1.63 | +$0.21 |
| Q1 2025 | -$1.24 | +$0.27 |
| Q4 2024 | -$0.69 | -$0.02 |
OI lost $7.79 per share over the past year, and its loss has widened in each of the last three quarters.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over OI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over OI on profitability, with a higher operating margin.
OI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6B | -1.8% |
| Q2 2026 | $1.7B | -2.2% |
| Q1 2026 | $1.5B | -1.7% |
| Q4 2025 | $1.5B | -1.9% |
| Q3 2025 | $1.7B | -1.5% |
| Q2 2025 | $1.7B | -1.3% |
| Q1 2025 | $1.6B | -1.6% |
| Q4 2024 | $1.5B | -6.8% |
OI's revenue has held roughly level: $1.6B last quarter, down 1.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.1% | -1.4 points |
| Q2 2026 | -50% | -50 points |
| Q1 2026 | -3.4% | -4.6 points |
| Q4 2025 | -48% | -40 points |
| Q3 2025 | 3.5% | +6.9 points |
| Q2 2025 | 0.4% | -5.6 points |
| Q1 2025 | 1.1% | -6.2 points |
| Q4 2024 | -8.2% | +19 points |
OI's operating margin was 2.1% last quarter, down 1.4 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
OI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $84M | -26% |
| Q2 2026 | -$1M | -102% |
| Q1 2026 | -$436M | -$130M |
| Q4 2025 | $309M | +47% |
| Q3 2025 | $114M | +107% |
| Q2 2025 | $51M | -43% |
| Q1 2025 | -$306M | +$177M |
| Q4 2024 | $210M | +33% |
OI has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
OI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +314K shares |
| 1 year | -0.9% | -1.4M shares |
| 3 years | -3.4% | -5.5M shares |
| 5 years | -4.2% | -6.7M shares |
| Available history | -0.9% | -1.4M shares |
OI has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $10M |
| Q4 2025 | $10M |
| Q3 2025 | $10M |
| Q2 2025 | $10M |
| Q1 2025 | $10M |
| Q4 2024 | $10M |
OI spent $20M buying back its own shares over the past year, down 50% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
OI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 10.9x | High |
| Q2 2025 | 14.9x | High |
| Q1 2025 | 11.0x | High |
| Q4 2024 | 8.1x | High |
| Q3 2024 | 20.8x | High |
| Q2 2024 | 12.6x | High |
| Q1 2024 | 11.2x | High |
| Q4 2023 | 7.3x | High |
OI's net debt is about 11 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
OI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.8 | Oversold |
| Stochastic | 5.3 | Oversold |
OI's weekly RSI is 30 (oversold) and its Stochastic is 5 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
OI PE vs Consumer Cyclical Sector
| Metric | OI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
OI has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over OI on trend strength, trading above more of its moving averages.
OI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.63 | 13% below |
| 20 week MA | $6.90 | 29% below |
| 50 week MA | $10.0 | 51% below |
| 100 week MA | $11.3 | 57% below |
| 200 week MA | $13.9 | 65% below |
OI is in a downtrend: it's below all five of its weekly moving averages, and 65% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over OI on returns for 2026, with the stronger performance.
OI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.9 | $11.5 | -3.3% |
| 2021 | $11.5 | $11.5 | +0.3% |
| 2022 | $11.5 | $16.9 | +46% |
| 2023 | $16.9 | $16.4 | -2.9% |
| 2024 | $16.4 | $10.3 | -37% |
| 2025 | $10.3 | $14.9 | +45% |
| 2026 YTD | $14.9 | $4.88 | -67% |
OI has finished lower in three of the last six years. It's down 67% so far in 2026.